-+ 0.00%
-+ 0.00%
-+ 0.00%

Median Technologies Subsidiary Eyonis Wins Rising Star Award for Lung Cancer Screening Software

PUBT·11/17/2026 06:32:08
Listen to the news
Median Technologies Subsidiary Eyonis Wins Rising Star Award for Lung Cancer Screening Software
  • Median Technologies subsidiary Eyonis won the 2026 Digital Health & AI Awards’ Rising Star award for its eyonis LCS lung cancer screening software.
  • The award was presented Nov. 16 at HLTH 2026 in Las Vegas.
  • eyonis LCS received FDA clearance in February 2026 and CE marking in July 2026; it is marketed in the US and Europe.
  • A 2,163-patient study showed 93.3% sensitivity and 92.4% specificity.
  • False positives fell 68%; false negatives declined 66% compared with unassisted radiologists.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Median Technologies SA published the original content used to generate this news brief on November 17, 2026, and is solely responsible for the information contained therein.